Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
about
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin combination therapy for vivax malariaGenetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapyFunctional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparumDihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, MalaysiaVivax malaria: neglected and not benignSulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolatesNovel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxIn vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Resistance to therapies for infection by Plasmodium vivaxActive case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of VanuatuAntibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries.Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of ChinaDifferent allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from ChinaPlasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaEfficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Monitoring resistance of Plasmdium vivax: point mutations in dihydrofolate reductase gene in isolates from Central China.Prescribing Pattern of Anti-malarial Drugs with Particular Reference to the use of Artesunate in Complicated Plasmodium Vivax CasesPlasmodium vivax dhfr mutations among isolates from malarious areas of IranEditing the Plasmodium vivax genome, using zinc-finger nucleasesDetection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.A new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparumDrug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.Plasmodium vivax treatments: what are we looking for?Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New GuineaPhenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.
P2860
Q24202910-2359ABEB-F16A-440C-B20A-980CED4CBD2AQ24235351-004E6DAE-33E3-4B52-B649-6EC212D29DFEQ24622539-ECACE365-687E-4C93-BEBE-A8CD513041FEQ28125913-9732D78D-5DCB-472C-9FF1-91E31812C230Q28481173-97B3B02E-F214-48FC-B06E-1669D6673E4BQ28550436-9D68F0C6-5473-405D-ADF8-74F1A4A6F58BQ29619167-AD19D032-4BFC-4EA9-B373-DDEC88E80FFDQ31064063-6CD35291-2FC4-4C2A-914F-47729AF15973Q31081389-5F50418C-2347-4FD1-B2FA-DFF25AB2C8A2Q31143848-7EDB3C3C-FDAC-4D2C-A43F-5418D1F8E137Q33259717-83C07A5D-317A-4BDC-A631-74D9E62933D1Q33276757-8417DBBA-84CD-4864-A718-63730443BD1FQ33279066-75F0CB4C-770D-44FB-BF2F-F61992261AD6Q33304430-3C1D1171-BE01-4F0B-A06B-5A50E2D94356Q33344896-1FB100AB-3A90-4C61-93DC-DBB5E4876DB4Q33344900-516A3B8B-632A-48D5-9047-43683C2BB5A8Q33371043-AF5E13CC-1353-4E56-908B-BB013C229C23Q33395221-6B0D6A65-0983-4268-A899-BC163C12463CQ33481576-6AF1E470-55F0-4392-8369-6EE4F6DD7419Q33549954-3F0B4C70-334D-4A60-84D1-9BF79A238E56Q33636850-54B4D398-A8C4-4840-A14F-FC8558D10CA3Q33766158-BE6F8F1D-A468-43E2-842C-52661B3AB88EQ34087282-9ADB57F8-E424-4342-982D-7E9D1A405B2DQ34168392-2F25512E-3C22-4431-8245-E4DA8E5E11A5Q34341770-97E4697D-79BC-4C51-83AB-82313E27D00DQ34596548-ADE39ACE-0E19-453B-8F66-3759D613F817Q34646141-78F49835-0AD9-4512-AC5C-4F8DBF689421Q35027170-C5151F16-BC39-4709-8CFB-51408BDFFD8AQ35046395-24F1215E-6D36-4301-AF3C-B89E774ECE07Q35062262-9A29BD4B-B231-4475-BFE2-445658FF1682Q35102663-2D12E194-34EB-49F9-8A44-1899BC0EB81EQ35179188-3912AE70-DBE8-4436-9370-014F8552BA8DQ35338795-46EC1DED-9ED1-40EB-B47A-02A80DF392DAQ35647659-8CCD57B2-7D86-45DA-B94B-3496BBE17573Q35698213-E0A8501C-3DED-4EDA-82AF-4277A5538753Q35760893-4CF2FFA1-F906-4AD3-B27B-CACF7AC6E579Q35784129-601A9877-8D08-4A39-AD13-22A63EDCFF68Q35941471-1F1DE4F4-EF72-4509-9802-13477165C6C0Q36144097-646AB652-68A4-462D-8658-CF44A5F79F6CQ36232661-D16B8217-EF69-4A68-8B86-EF10A8007D8D
P2860
Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@ast
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@en
type
label
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@ast
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@en
prefLabel
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@ast
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@en
P2093
P2860
P921
P1476
Therapeutic efficacies of arte ...... asmodium vivax dhfr mutations.
@en
P2093
Joanne Baker
Sri Suprianto
P2860
P304
P356
10.1128/AAC.46.12.3947-3953.2002
P407
P577
2002-12-01T00:00:00Z